Alan Kopin

Alan Kopin

Company: On Target Therapeutics

Job title: Co-Founder & Chief Scientific Officer

Seminars:

A Lipidated Protease-Resistant Chemerin Peptide Offers a Novel Therapeutic for Dry Eyes 2:45 pm

A systematic approach to developing lipidated peptide ligands In vitro and in vivo testing of lipidated stable chemerin Moving from preclinical studies into the clinicRead more

day: Day One

Panel Discussion: What Does the Next 5 Years of GPCR Drug Discovery & Development Look Like? 9:00 am

Exploring the current lay of the land; which GPCRs show most promise now and where does the future lie? What technologies are the most exciting right now and will propel the field forward? How do we increase the number of antibody therapeutics in the GPCR marketRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.